Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound pain-stopping and inflammation-diminishing anticarcinogen capsule

An analgesic, anti-inflammatory, powerful technology applied in the field of oral medicine

Inactive Publication Date: 2003-06-04
李广义
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The finished product belongs to each component and the raw materials are evenly mixed in proportion and loaded into capsules

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0014] The manufacturing process of the invention is simple, and the workshop, raw materials, process and quality are monitored according to GMP certification.

[0015] The raw material preparation includes 0.195 grams of acetylsalicylic acid, 0.1 grams of paracetamol, and 0.004 grams of prednisone per capsule.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention is one kind of class-II medicine for stopping pain, diminishing inflammation and resisting cancer. It may be used to improve the survival quality of cancer patient and prolong the survival period of cancer patient. It may be used to replace morphine and will produce no dependence. It is one oral medicine without toxicity and anaesthesia; may be used to treat pain caused by Raynauds disease, angiospasm and zoster. It has obvious curative effect on diabetes as well as rheumatism, rheumatoid disease, scapulohumeral periarthritis and phlebitis.

Description

technical field [0001] The present invention relates to an oral drug with powerful analgesic properties, anti-inflammation and anti-cancer properties, which can be used for "II-III ladder analgesia" of cancer. Background technique [0002] For more than 100 years, medical researchers have been seeking drug treatment for cancer "II-III ladder analgesia", and they have been focusing on morphine or analgesics that change the structure of morphine and psychotropic drugs, so that "ice poison" appears Such criminal drugs that endanger mankind. There are also drugs that change the structure of morphine and opioids plus non-steroidal anti-inflammatory drugs (NSAIDs) such as: "codeine" plus "paracetamol" and the recently developed prescription of "Johnson & Johnson" in the United States. "Oxycodone" plus "Paracetamol" and "Tylerin" all have morphine-like adverse reactions (ADR). The "opioid" ADR of "oxycodone" is not optimistic. Contents of the invention [0003] The purpose of ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P29/00A61P35/00
Inventor 李广义
Owner 李广义
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com